Oziltus 70 mg/mL
denosumab-mobz · INJECTION, SOLUTION · Amneal Pharmaceuticals LLC
No Recall History
Plain English
Oziltus is a injection, solution containing denosumab-mobz at 70 mg/mL, taken subcutaneous. Manufactured by Amneal Pharmaceuticals LLC.
Key Facts
- Brand Name
- Oziltus
- Generic Name
- denosumab-mobz
- NDC Code (Product)
70121-2701- Manufacturer
- Amneal Pharmaceuticals LLC
- Strength
- 70 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761457
- Drug Class
- RANK Ligand Inhibitor [EPC]
- Marketing Start
- 12/23/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Oziltus used for?
Oziltus contains denosumab-mobz. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Oziltus a controlled substance?
Oziltus is not classified as a controlled substance by the DEA.
What is the generic name for Oziltus?
The generic name for Oziltus is denosumab-mobz. There are 1 other brand versions of denosumab-mobz.
What is the NDC code for Oziltus 70 mg/mL?
The NDC (National Drug Code) for Oziltus 70 mg/mL is 70121-2701, listed by Amneal Pharmaceuticals LLC.